Fundraising Fox

Graziano Seghezzi

Investor

Managing Partner at Sofinnova Partners

Paris, France

Writes $100K – $5M checks · typically $1.5M

About

Managing Partner at Sofinnova Partners since 2006 and part of the Sofinnova Capital Strategy team, focused on biotech company creation. He has led numerous exits (including Mablink, Corvidia, GlycoVaxyn, and Omthera) and drove the firm's expansion in Italy, founding the BiovelocITA accelerator and the Sofinnova Telethon Fund. He began his VC career at Sofinnova in 2001, worked at Index Ventures (2003-2006), and previously did academic oncology and cardiovascular research at NYU School of Medicine.

Invests in

Biotech

Experience

  1. Sofinnova PartnersManaging Partnercurrent2017 — present
  2. Sofinnova PartnersPartner2006 — 2017
  3. Index VenturesPrincipal2003 — 2006
  4. Sofinnova PartnersVenture Consultant2002 — 2003Paris, Île-de-France, France
  5. NYU Langone Medical CenterPostdoc1996 — 2000

Education

  1. Rotterdam School of Management, Erasmus UniversityMaster of Business Administration (MBA), Entrepreneurship/Entrepreneurial Studies2000 — 2002
  2. Università di PaviaBiological Sciences, Genetics and Microbiology

Skills & more

Mergers & Acquisitions1Strategy6Start-ups5Venture Capital5Business Strategy2Due DiligenceEntrepreneurshipManagementStrategic PlanningBusiness DevelopmentPrivate EquityLife Sciences1

Languages English · French · Italian

From Graziano's professional profile.

Same school

Shared employers

Deals · 2

Hookipa PharmaBoard seat

via Sofinnova Partners · filed Feb 2019

CORVIDIA THERAPEUTICS, INC.Board seat

via Sofinnova Partners · filed May 2018 · $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Sofinnova Partners